Company Update (NASDAQ:IMGN): ImmunoGen, Inc. Reports Second Quarter Fiscal …

Company Update (NASDAQ:IMGN): ImmunoGen, Inc. Reports Second Quarter Fiscal …

ImmunoGen, Inc. (NASDAQ:IMGN), a biotechnology company that develops targeted anticancer therapeutics using its proprietary ADC technology, today reported financial results for the three-month period ended December 31, 2015 – the second quarter of …

(Visited 1 times, 1 visits today)
4
Like
Save

Comments

Comments are disabled for this post.